Lung Cancer
Volume 62, Issue 1 , Pages 72-77 , October 2008

Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer

  • Se Hoon Park

      Affiliations

    • Division of Hematology and Oncology, Department of Medicine, Sungkyunkwan University Samsung Medical Center, Seoul 135-710, Republic of Korea
    • ,
  • Junshik Hong

      Affiliations

    • Division of Hematology and Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 405-760, Republic of Korea
    • ,
  • Young Saing Kim

      Affiliations

    • Division of Hematology and Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 405-760, Republic of Korea
    • ,
  • Yujin Kim

      Affiliations

    • Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 405-760, Republic of Korea
    • ,
  • Sun Young Kyung

      Affiliations

    • Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 405-760, Republic of Korea
    • ,
  • Chang Hyeok An

      Affiliations

    • Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 405-760, Republic of Korea
    • ,
  • Sang Pyo Lee

      Affiliations

    • Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 405-760, Republic of Korea
    • ,
  • Jeong Woong Park

      Affiliations

    • Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 405-760, Republic of Korea
    • ,
  • Sung Hwan Jeong

      Affiliations

    • Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 405-760, Republic of Korea
    • ,
  • Jinny Park

      Affiliations

    • Division of Hematology and Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 405-760, Republic of Korea
    • ,
  • Eun Kyung Cho

      Affiliations

    • Division of Hematology and Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 405-760, Republic of Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 32 460 3817; fax: +82 32 460 3233.
    • ,
  • Dong Bok Shin

      Affiliations

    • Division of Hematology and Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 405-760, Republic of Korea
    • ,
  • Jae Hoon Lee

      Affiliations

    • Division of Hematology and Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 405-760, Republic of Korea

Received 22 October 2007 ,Revised 1 February 2008 ,Accepted 1 February 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0169-5002(08)00059-7

doi: 10.1016/j.lungcan.2008.02.001

Lung Cancer
Volume 62, Issue 1 , Pages 72-77 , October 2008

Article Tools

* Image Usage & Resolution